KRAS and the Reality of Personalized Medicine in Non-Small Cell Lung Cancer

Overview of attention for article published in Molecular Medicine, July 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 3 X users
patent: 1 patent

reddit: 1 Redditor

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Patents Reddit Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

COMBINATION OF A MAPK PATHWAY INHIBITOR AND AN ANTISENSE COMPOUND TARGETED TO KRAS

Application WO-2018146316-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.